I et studie blev patienter med type 2- diabetes, der var utilstrækkeligt kontrolleret med oral hypoglykæmisk stof alene, randomiseret til behandling med NovoMix 30 to gange daglig (117 patienter) eller insulin glargin en gang daglig (116 patienter).
In one study, patients with type 2 diabetes, insufficiently controlled on oral hypoglycaemic agents alone, were randomised to treatment with twice daily NovoMix 30 (117 patients) or once daily insulin glargine (116 patients).